Documento fuente o registro público

FDA 510(k) K232404 — CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDES

FDA 510(k) index record K232404. Device: CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDES. Applicant as listed: Medicon Hellas S.A. Decision date: 2024-08-09.

OtherU.S. Food and Drug Administration (FDA)2024-08-09

Fuente

"device_name": "CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDES"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K232404.

Device name: CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDES. Applicant as listed: Medicon Hellas S.A.

Decision date: 2024-08-09. Decision wording: Substantially Equivalent.

Product code: CHH. Regulation: 21 CFR 862.1175. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más